83 -4 (32/2) 2020 — Hamdamov U.R. — MODERN TREATMENT OF VENOUS THROMBOEMBOLIC COMPICATIONS WITH ANTICOAGULANTS: POSSIBLE RIVAROXABAN
MODERN TREATMENT OF VENOUS THROMBOEMBOLIC COMPICATIONS
WITH ANTICOAGULANTS: POSSIBLE RIVAROXABAN
Hamdamov U.R. -Bukhara Branch of Republic Scientific Center of Emergency Medical Care
Resume
A prospective clinical study was carried out to assess the efficacy, safety and convenience of the main therapy for venous thrombosis with an oral anticoagulant from the first day of treatment. The study included patients admitted to the surgical department of the Bukhara branch of the RSCEMP with instrumentally verified acute deep vein thrombosis of the lower extremities. The study included 47 patients who, starting from the first day, were prescribed an anticulant at 15 mg 2 times a day for up to 3 weeks from the start of therapy, then switched to a single daily tablet form at a clinical dose of up to 20 mg of drugs. The duration of treatment was 3 months for distal thrombosis, 6 months for provoked proximal venous thrombosis with reversible risk factors; for a long time (more than 12 months) with idiopathic, recurrent DVT, as well as venous thrombosis, which developed against the background of the presence of irreversible risk factors (cancer).
Over the entire observation period, no hemorrhagic complications, recurrence or progression of venous thrombosis, or the development of pulmonary embolism were recorded. Research has shown that once daily use of anticoagulants provides good adherence to treatment and a low risk of bleeding.
Key words: venous thromboembolic complications, deep vein thrombosis, oral anticoagulants, pulmonary embolism
First page
342
Last page
345
For citation: Hamdamov U.R., Modern treatment of venous thromboembolic compications with anticoagulants: possible rivaroxaban//New Day in Medicine 4(32)2020 342-345 https://cutt.ly/RzwL9R0
List of References
- Богачев В.Ю., Болдин Б.В., Родионов С.В. Амбулаторное лечение тромбоза глубоких вен нижних конечностей. Новые возможности и перспективы. Амбулаторная хирургия. 2017;1-2 (6566).
- Бокерия Л.А., Затевахин И.И., Кириенко А.И. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология 2015; 5-6.
- Кириенко А.И., Андрияшкин В.В. Флебологическая помощь больным с осложненными формами хронической венозной недостаточности на амбулаторном этапе. Флебология № 2 том 8 2014; 117-118.
- Кривощеков Е.П., Романов В.Е., Дмитриева И.А. Консервативное лечение осложненных форм хронической венозной недостаточности на фоне сахарного диабета. Флебология № 2 том 8 2014; 118.
- Савельев В.С., Кириенко А.И., Золотухин И.А., Андрияшкин В.В. Профилактика послеоперационных венозных тромбоэмболических осложнений в российских стационарах. Флебология № 3 2010; 3-8.
- Шилова А.Н., Карпенко А.А., Кармодонова Н.А., Старосоц- кая М.В., Особенности терапии ТЭЛА при гематогенной тромбофилии. Ангиология и сосудистая хирургия том. 19 № 3 2013;71- 73.
- Angelli G. Current issues in anticoagulation. Patophysiol. Haemost. Tromb. 2005; 2-9.
- EIN STEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. Engl Med 2010; 2499-2510.
- Dmitrieva I, Krivoshchekov E. Flebological help patients with complicated forms of chronic venous insufficitncy. 24 Conference of the European Wound Management Association EWMA 2014 Madrid Spain Espana 2014; 360.
- GuyattG.H. AklE.A., CrowtherM. Gutterman D.D., Schuunemann H.J. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 7-47.